SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

21 Sep 2020 15:02

RNS Number : 6230Z
Caledonia Investments PLC
21 September 2020
Β 

Caledonia Investments plc

Β 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

Β 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving persons closely associated with one of its directors, Jamie Cayzer-Colvin.

Β 

On 16 September 2020:

Β 

(i) A family trust in which Mr Cayzer-Colvin holds a beneficial interest sold 1,000 Shares, representing 0.002% of the Company's total issued ordinary share capital, to a registered charity of which Mr Cayzer-Colvin is a trustee. All Shares were sold at 2562.5p per share. The transaction decreased Mr Cayzer-Colvin's beneficial holdings and increased his non-beneficial holdings in the Company. The transaction took place in London.

Β 

(ii) Mr Cayzer-Colvin was appointed as a trustee of a family trust. The trust holds 16,237 Shares in the Company, representing 0.029% of the Company's total issued ordinary share capital. Mr Cayzer-Colvin's appointment increases his non-beneficial holdings in the Company.

Β 

(iii) A family trust in which Mr Cayzer-Colvin holds a beneficial interest appropriated 3,529 Shares in the Company, representing 0.006% of the Company's total issued share capital, between two of its funds. All Shares were appropriated at 2550p per share. There was no change to Mr Cayzer-Colvin's beneficial or non-beneficial holdings in the Company as a result of the transaction. The transaction was conducted off-market and in London.

Β 

Mr Cayzer-Colvin's total interests in Shares following the above transactions are as follows:

Β 

Beneficial - 374,913 Shares = 0.68%

Non-beneficial - 150,273 Shares = 0.27%

Performance share scheme awards - 76,807 Shares = 0.14%

Deferred bonus plan awards - 5,619 Shares = 0.01%

Β 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Β 

Enquiries:

R Webster

Company Secretary

Tel: +44 20 7802 8080

Β 

21 September 2020

Β 

APPENDIX

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Lord Cayzer Will Trust

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, an Executive Director

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale of shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£25.625

1,000

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

16 September 2020

f)

Β 

Place of the transaction

Β 

London - XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

The Moorview Charitable Trust

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, an Executive Director

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£25.625

1,000

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

16 September 2020

f)

Β 

Place of the transaction

Β 

London - XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

P Bromage Settlement

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, an Executive Director

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Appointment as a trustee of P Bromage Settlement resulting in James Cayzer-Colvin acquiring a non-beneficial interest in 16,237 ordinary shares

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

N/A

16,237

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

16 September 2020

f)

Β 

Place of the transaction

Β 

N/A

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

ABT Cayzer Baronetcy Trust

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, an Executive Director

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Appropriation of 3,529 ordinary shares between two of funds of the Trust

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£25.50

3,529

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

16 September 2020

f)

Β 

Place of the transaction

Β 

London - outside a trading venue

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHSEFFLFESSESU
Date   Source Headline
19th Jun 20189:12 amRNSAnnual Financial Report
6th Jun 201812:47 pmRNSNet Asset Value(s)
31st May 20185:11 pmRNSTotal Voting Rights
31st May 20183:00 pmRNSDirector/PDMR Shareholding
31st May 20189:17 amRNSDirector/PDMR Shareholding
25th May 20185:02 pmRNSTransaction in Own Shares
24th May 20185:11 pmRNSFinal Results - Correction
24th May 20187:00 amRNSFinal Results
4th May 201810:31 amRNSNet Asset Value(s)
13th Apr 20184:31 pmRNSHolding(s) in Company
9th Apr 201811:51 amRNSNet Asset Value(s)
29th Mar 20183:33 pmRNSTransaction in Own Shares
6th Mar 201810:03 amRNSNet Asset Value(s)
15th Feb 20183:14 pmRNSDirector/PDMR Shareholding
6th Feb 20181:14 pmRNSNet Asset Value(s)
8th Jan 201812:31 pmRNSDirector/PDMR Shareholding
5th Jan 20181:24 pmRNSReport for the quarter ended 31 Dec 2017
5th Jan 20181:19 pmRNSNet Asset Value(s)
2nd Jan 20189:49 amRNSBlock listing Interim Review
20th Dec 201710:44 amRNSDirector/PDMR Shareholding
12th Dec 20178:57 amRNSHalf-year Report
6th Dec 201712:20 pmRNSNet Asset Value(s)
30th Nov 20175:29 pmRNSDirector/PDMR Shareholding
30th Nov 201711:39 amRNSDirectorate Change
23rd Nov 20177:00 amRNSHalf-year Report
6th Nov 20173:23 pmRNSNet Asset Value(s)
1st Nov 20179:24 amRNSHolding(s) in Company
30th Oct 20174:08 pmRNSDisposal
6th Oct 201711:33 amRNSNet Asset Value(s)
5th Oct 20178:45 amRNSHolding(s) in Company
3rd Oct 20179:21 amRNSHolding(s) in Company
29th Sep 201711:21 amRNSHolding(s) in Company
8th Sep 20178:48 amRNSDirectorate Change
6th Sep 20178:53 amRNSNet Asset Value(s)
21st Aug 20179:50 amRNSChange of Registered Office
18th Aug 20179:59 amRNSHolding(s) in Company
4th Aug 20173:46 pmRNSNet Asset Value(s)
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
20th Jul 20173:28 pmRNSResult of AGM
6th Jul 20173:11 pmRNSReport for quarter ended 30 June 2017
6th Jul 20172:51 pmRNSNet Asset Value(s)
6th Jul 20172:24 pmRNSIncrease in committed bank facilities
6th Jul 20171:11 pmRNSDirector/PDMR Shareholding
5th Jul 20173:22 pmRNSHolding(s) in Company
3rd Jul 20178:45 amRNSBlock listing Interim Review
29th Jun 20173:01 pmRNSDisposal
27th Jun 20177:00 amRNSCapital Markets Day
13th Jun 20179:14 amRNSAnnual Financial Report
12th Jun 20173:17 pmRNSDirector/PDMR Shareholding
8th Jun 20172:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.